Results 11 to 20 of about 4,121 (154)

Elevated Serum Lipopolysaccharides and Intrinsic Factor Autoantibodies Correlate With Macrocytic Anemia Among People With HIV. [PDF]

open access: yesImmun Inflamm Dis
ABSTRACT Introduction Human immunodeficiency virus (HIV) infection is associated with various comorbidities, including macrocytic anemia, though the role of the infection is unclear. HIV has been implicated in microbial translocation and altered immune responses.
Amakye D   +6 more
europepmc   +2 more sources

Pseudothrombocytosis in a patient with severe burns. [PDF]

open access: yesBr J Haematol
British Journal of Haematology, Volume 208, Issue 2, Page 397-398, February 2026.
Kennedy SJ.
europepmc   +2 more sources

Higher gastric parietal cell antibody titer significantly increases the frequencies of macrocytosis, serum vitamin B12 deficiency, and hyperhomocysteinemia in patients with burning mouth syndrome

open access: yesJournal of Dental Sciences, 2022
Background/purpose: Our previous study found 109 gastric parietal cell antibody (GPCA)-positive burning mouth syndrome (BMS) patients (so-called GPCA+BMS patients in this study) in a group of 884 BMS patients.
Ying-Tai Jin   +5 more
doaj   +1 more source

Increased mean corpuscular volume as a predictor of response during bevacizumab treatment [PDF]

open access: yesArchive of Oncology, 2012
Background: Remission during sunitinib (a multikinase inhibitor and antiangiogenic drug) treatment correlates with appearance of macrocytosis. There are some suggestions that bevacizumab, an antiangiogenic drug, may result in macrocytosis as well ...
Zygulska Lidia Aneta   +1 more
doaj   +1 more source

Clinicopathological features of pancytopenia in adults and the role of bone marrow study in etiological categorization: A one-year cross-sectional study

open access: yesMedical Journal of Babylon, 2022
Background and Objectives: Pancytopenia is a combination of anemia (with a reduction of the red blood cell count), leukopenia, and thrombocytopenia. Leukopenia is usually mainly due to a reduction in the neutrophil count although the number of other ...
Abhinab Bhuyan   +2 more
doaj   +1 more source

Anemia, hematinic deficiencies, and hyperhomocysteinemia in serum gastric parietal cell antibody-positive burning mouth syndrome patients without serum thyroid autoantibodies

open access: yesJournal of Dental Sciences, 2021
Background/purpose: Our previous study found that 70 of 884 burning mouth syndrome (BMS) patients have serum gastric parietal cell antibody (GPCA) positivity but without thyroglobulin antibody (TGA) and thyroid microsomal antibody (TMA) (so-called GPCA ...
Ying-Tai Jin   +5 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Integrating Red Blood Cell Features and Hemoglobin Levels in Metastatic Renal Cell Carcinoma Patients Treated with Pazopanib or Cabozantinib: An Easily Exploitable Prognostic Score

open access: yesFrontiers in Bioscience-Elite, 2023
Background: The advent of immune checkpoint inhibitors (ICIs) has revolutionized the metastatic renal cell carcinoma (mRCC) therapeutic landscape. Nevertheless, tyrosine-kinase inhibitors (TKIs) targeting the vascular endothelial growth factor (VEGF ...
Giulia Mazzaschi   +24 more
doaj   +1 more source

Hematinic deficiencies, hyperhomocysteinemia, and gastric parietal cell antibody positivity in atrophic glossitis patients with macrocytosis

open access: yesJournal of the Formosan Medical Association, 2019
Background/Purpose: Macrocytosis is defined as having the mean corpuscular volume (MCV) ≧ 100 fL. This study evaluated whether 41 atrophic glossitis (AG) patients with macrocytosis had significantly higher frequencies of anemia, hematinic deficiencies ...
Chun-Pin Chiang   +5 more
doaj   +1 more source

The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study

open access: yesTherapeutic Advances in Urology, 2023
Background: Tyrosine-kinase inhibitors (TKIs) and immunotherapy represent the backbone treatment for metastatic renal cell carcinoma (mRCC) patients. The aim of the present study was to describe mean corpuscular volume (MCV) and red cell distribution ...
Chiara Tommasi   +19 more
doaj   +1 more source

Home - About - Disclaimer - Privacy